Claim your complimentary gift of my exclusive mini weight care guide today!

Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)

Tripling the dose of Wegovy sounds intense — so why are researchers doing it, and who is it actually for?

For a long time, 2.4 mg weekly was considered the ceiling for Wegovy. But a newer option quietly entered the conversation: Wegovy HD, a 7.2 mg weekly dose of semaglutide. And despite how big that jump sounds on paper, there surprisingly hasn't been that much discussion around it yet.

As weight management treatment continues to move fast, higher-dose options are starting to expand what's possible — not necessarily for everyone, but for the right patient in the right situation.

In this episode, we're breaking down what we know so far about Wegovy's new 7.2 mg dose — the data, the side effects, and who it may or may not be right for:

• Why Wegovy's dose just tripled — and what the clinical data actually shows
• What GI side effects really look like at 7.2 mg, and when they're most likely to hit
• The unexpected skin sensation side effect that showed up in the higher-dose trial
• How to know if you're actually a good candidate for the higher dose
• Who the 7.2 mg dose is approved for — and who it isn't

The goal isn't to push everyone toward a higher dose. It's to make sure that if this option is relevant to you or someone you care about, you actually know it exists — and you have the full picture to bring into that conversation with your doctor. Tune into the full episode for the complete breakdown, because weight management treatment is moving fast, and being informed is the first step to making the right call for your health.

Connect with me:

• Instagram: doctorfrancavilla
• Facebook: Help Your Patients Lose Weight with Dr. Francavilla
• Website: Dr. Francavilla Show
• Youtube: The Doctor Francavilla Show
• GLP Strong: glpstrong.com